These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. New Insights into the Crosstalk between NMDARs and Iron: Implications for Understanding Pathology of Neurological Diseases. Xu H; Jiang H; Xie J Front Mol Neurosci; 2017; 10():71. PubMed ID: 28360837 [TBL] [Abstract][Full Text] [Related]
27. [Role of glutamate and excitotoxicity in neurologic diseases]. Hugon J; Vallat JM; Dumas M Rev Neurol (Paris); 1996 Apr; 152(4):239-48. PubMed ID: 8763652 [TBL] [Abstract][Full Text] [Related]
28. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Hynd MR; Scott HL; Dodd PR Neurochem Int; 2004 Oct; 45(5):583-95. PubMed ID: 15234100 [TBL] [Abstract][Full Text] [Related]
30. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope. Sonkusare SK; Kaul CL; Ramarao P Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530 [TBL] [Abstract][Full Text] [Related]
31. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. Léveillé F; El Gaamouch F; Gouix E; Lecocq M; Lobner D; Nicole O; Buisson A FASEB J; 2008 Dec; 22(12):4258-71. PubMed ID: 18711223 [TBL] [Abstract][Full Text] [Related]
33. New targets for pharmacological intervention in the glutamatergic synapse. Gardoni F; Di Luca M Eur J Pharmacol; 2006 Sep; 545(1):2-10. PubMed ID: 16831414 [TBL] [Abstract][Full Text] [Related]
34. Dopamine depletion of the striatum causes a cell-type specific reorganization of GluN2B- and GluN2D-containing NMDA receptors. Zhang X; Chergui K Neuropharmacology; 2015 May; 92():108-15. PubMed ID: 25619731 [TBL] [Abstract][Full Text] [Related]
35. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Parsons MP; Raymond LA Neuron; 2014 Apr; 82(2):279-93. PubMed ID: 24742457 [TBL] [Abstract][Full Text] [Related]
36. GLT-1 transporter: an effective pharmacological target for various neurological disorders. Soni N; Reddy BV; Kumar P Pharmacol Biochem Behav; 2014 Dec; 127():70-81. PubMed ID: 25312503 [TBL] [Abstract][Full Text] [Related]
37. Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases. Seillier C; Lesept F; Toutirais O; Potzeha F; Blanc M; Vivien D Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142247 [TBL] [Abstract][Full Text] [Related]
38. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Fan MM; Raymond LA Prog Neurobiol; 2007 Apr; 81(5-6):272-93. PubMed ID: 17188796 [TBL] [Abstract][Full Text] [Related]